Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DNA Vaccines
Research from University of California, Medical Department yields new findings on DNA vaccines
June 10th, 2009
According to a study from the United States, "Simian immunodeficiency virus (SIV) infection of rhesus macaques is a valuable animal model for human immunodeficiency virus (HIV)-1 vaccine development. Our laboratory recently described the immunogenicity and limited efficacy of a vif-deleted SIVmac239 proviral DNA (SIV/CMV Delta vif) vaccine." "The current report characterizes immunogenicity and efficacy for the SIV/CMV Delta vif proviral DNA vaccine when co-inoculated with an optimized rhesus interleukin (rIL)-15 expression plasmid. Macaques co-inoculated with rIL-15 and SIV/CMV Delta vif proviral plasmids showed significantly improved SIV-specific CD8 T cell immunity...
Source: Vaccine Weekly (2009-06-10)
|
